Literature DB >> 12212580

[Advice of the French Superior Council on Public Health (section on transmissible diseases) relative to vaccination by heptavalent pneumococcal conjugate vaccine (Prevanar). Meeting of March 8, 2002].

.   

Abstract

This article is the full-length text (including arguments and recommendations) written by the Conseil Supérieur d'Hygiène Publique de France, in its session of march 8th 2002, expressing its opinion on the immunization policy with the heptavalent pneumococcal conjugate vaccine (Prevenar).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12212580

Source DB:  PubMed          Journal:  Arch Pediatr        ISSN: 0929-693X            Impact factor:   1.180


  2 in total

1.  Decline in pneumococcal meningitis after the introduction of the heptavalent-pneumococcal conjugate vaccine in northern France.

Authors:  F Dubos; I Marechal; M O Husson; C Courouble; M Aurel; A Martinot
Journal:  Arch Dis Child       Date:  2007-07-11       Impact factor: 3.791

2.  Antibiotic innovation may contribute to slowing the dissemination of multiresistant Streptococcus pneumoniae: the example of ketolides.

Authors:  Lulla Opatowski; Laura Temime; Emmanuelle Varon; Roland Leclercq; Roland Leclerc; Henri Drugeon; Pierre-Yves Boëlle; Didier Guillemot
Journal:  PLoS One       Date:  2008-05-07       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.